Piramal Pharma Completes Acquisition of Controlling Stake in Yapan Bio

Piramal Pharma Limited has completed the acquisition of a controlling stake in Yapan Bio Private Limited, the company announced Wednesday. This acquisition enhances Piramal's position in the biologics manufacturing sector.

Yapan Bio specializes in process development, characterization, and Phase I and II GMP manufacturing services for vaccines and biologics. Piramal had previously held a stake in Yapan Bio since 2021.

The transaction is expected to significantly expand Piramal's service offerings within the biologics space, supporting clients from early-stage development through to commercial manufacturing.

This move is anticipated to bolster Piramal's capacity to meet the growing demand for biologics manufacturing services.